Company / Assets per Share
Corcept Therapeutics Incorporated Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$7.96
FY2025
5-year range
$3.63 / $8.13
FY2021-FY2025
Trend
-2.1%
vs FY2024
Sector context
#115 of 210
Health Care
What the data says
At $7.96, Corcept Therapeutics Incorporated's assets per share ranks #115 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $0.63 in FY2016 to $8.13 in FY2024.
Based on SEC 10-K filings.
7.96 in FY2025 with a 5-year CAGR of +9.8%.
Improved from $5.76 to $7.96 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +13.1%
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
#115 of 210 in Health CareTop 55% of 210This company $7.96 Sector average $296.79
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 2.1% year-over-year.
- Ranks #115 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2024.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.96 | -2.1% |
| FY2024 | $8.13 | +41.0% |
| FY2023 | $5.76 | +4.7% |
| FY2022 | $5.51 | +51.7% |
| FY2021 | $3.63 | -27.3% |
| FY2020 | $4.99 | +39.2% |
| FY2019 | $3.58 | +31.9% |
| FY2018 | $2.72 | +38.9% |
| FY2017 | $1.96 | +212.0% |
| FY2016 | $0.63 | +22.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026